ExodusPoint Capital Management LP, a prominent institutional investor, has significantly increased its stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) in the ...
Landscape Capital Management L.L.C., a prominent investment firm, has recently acquired a new stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). According ...
Pictet Asset Management SA, a prominent institutional investor, has increased its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) by 6.3% during ...
BioCryst Pharmaceuticals (NASDAQ:BCRX), a biotechnology company, recently received coverage from equities research analysts at StockNews.com. The analysts issued a "hold" ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a biotechnology company known for its innovative pharmaceutical products, has garnered positive attention from investment analysts ...
August 16, 2023 Victory Capital Management Inc., a prominent investment management firm, has recently made a significant change to its ...
August 8, 2023 - BioCryst Pharmaceuticals (NASDAQ:BCRX) has recently released its quarterly earnings report, revealing some interesting insights into the ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a renowned biopharmaceutical company, experienced a notable surge in its shares during trading on Friday, August ...
In recent news, BioCryst Pharmaceuticals (NASDAQ:BCRX) has had its price objective increased by analysts at Royal Bank of Canada. The ...
On August 4, 2023, Brian Abrahams, an analyst at RBC Capital, reaffirmed his stance on BioCryst Pharma (NASDAQ:BCRX) with a ...